The Department of Justice is investigating Andreessen Horowitz over potential antitrust violations tied to board seat conflicts at two data infrastructure companies, marking a rare regulatory challenge to venture capital's traditional operating model.
The probe centers on two a16z partners: Ben Horowitz sits on the board of Databricks, while Martin Casado serves on Fivetran's board. Both companies operate in the data pipeline and analytics space, creating what regulators view as a potential conflict of interest. The investigation has been underway for nearly a year and invokes the Sherman Act, a 112-year-old antitrust statute rarely deployed against venture firms.
The timing matters. When a16z first invested in these companies, Databricks and Fivetran occupied different market positions. Fivetran focused on data integration and extraction, while Databricks built data lakehouse infrastructure. Over time, their product roadmaps have converged, pushing both toward broader data operations platforms. That overlap triggered DOJ scrutiny.
Board seats represent a core part of how venture capital firms add value beyond capital. A16z partners have traditionally held multiple board positions across portfolios, giving them oversight and influence. This arrangement helps a16z shape strategy, access information, and strengthen founder relationships. The practice is standard across Sand Hill Road. Sequoia Capital, Kleiner Perkins, Benchmark, and other top-tier firms routinely place partners on multiple boards within related verticals.
The Sherman Act violation would hinge on whether a16z used its dual board positions to suppress competition, coordinate strategy, or share competitively sensitive information between the two companies. The DOJ would need to prove that the arrangement harmed competition or consumer welfare in the data infrastructure market. Simply holding overlapping board seats isn't illegal on its own. The intent and execution matter.
This investigation opens uncomfortable questions for venture capital's governance standards. The VC model assumes that sophisticated founders and board members will manage conflicts appropriately. Self-regulation has been the norm. A16z has formal conflict-of-interest policies, but those internal guidelines don't prevent a partner from sitting on boards of adjacent competitors if both companies consent.
The Sherman Act angle is notable because it's an aggressive prosecutorial choice. Rather than using modern merger rules or FTC Act provisions, the DOJ invoked a statute typically reserved for cartels and explicit collusion. That suggests regulators view the board overlap as more than a governance mishap. They may see evidence of information sharing or coordinated action between the two companies.
For venture capital broadly, this probe threatens to constrain how partners deploy their expertise and networks. If the DOJ wins on Sherman Act grounds, a16z could face injunctions forcing Horowitz and Casado to resign from one board each. Other VCs would likely face similar pressure to abandon overlapping board seats in competitive markets.
The implications ripple beyond a16z. Venture firms have built successful models on deep operational involvement through board seats. Restricting that leverage could reshape how VCs add value to portfolio companies. It might also slow information flow and governance expertise, ultimately hurting founders who benefit from experienced operators in the boardroom.
The investigation remains ongoing. If the DOJ pursues charges, expect aggressive discovery into internal communications between a16z and both companies. The outcome will likely establish new precedent for how closely venture capital can monitor competing portfolio companies without triggering antitrust liability.